Alzheimer disease (AD) is the sixth leading cause of death in the United States and is projected to affect over 13 million ...

Weill Cornell Medicine researchers have received a five-year $6.2 million grant from the National Institute on Aging, part of the National Institutes of Health, to build a portable, high-resolution ...

Weill Cornell Medicine researchers have received a five-year, $6.2 million grant from the National Institute on Aging, part of the National Institutes ...

When I co-invented the first PET (positron emission tomography) scan to visualize brain amyloid and tau—the physical evidence of Alzheimer’s disease—I did not foresee the distressing mental ...

King Faisal Specialist Hospital & Research Centre (KFSHRC) and Eli Lilly Saudi Arabia Limited (Lilly) have signed a ...

With Eisai and Biogen’s Leqembi and Eli Lilly’s Kisunla launching onto the market, the 2024 Clinical Trials of Alzheimer’s ...

RIYADH, Saudi Arabia, Nov. 03, 2024 (GLOBE NEWSWIRE) -- (KFSHRC) and Eli Lilly Saudi Arabia signed an MoU today to improve ...

Eli Lilly Saudi Arabia and King Faisal Specialist Hospital & Research Centre (KFSHRC) have teamed up to make KFSHRC’s Neuroscience Centre a top regional hub for Alzheimer’s disease treatment.

The memorandum of understanding (MOU) between the companies aims to advance the development of imaging agents used in PET scans.

Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...